Anti-GAD65 antibodies have been associated with various syndromes including encephalitis, stiff person syndrome (SPS), cerebellar ataxia, epilepsy, and type 1 diabetes [25, 39–42]. The gene discussed is GAD2; the disease is stiff-person syndrome.